PROTALEX, INC. Stock Option Agreement (this “Agreement”)Stock Option Agreement • October 13th, 2015 • Protalex Inc • Services-commercial physical & biological research
Protalex, Inc., a Delaware corporation (the “Company”), hereby grants to Kirk Warshaw (the “Optionee”), a stock option to purchase a total of 250,000 shares of the Company's Common Stock, par value $.00001 per share (the “Common Stock”), at a price of $5.41 per share (the “Exercise Price”).
Protalex, Inc.Agreement to Convert Outstanding Debt • October 13th, 2015 • Protalex Inc • Services-commercial physical & biological research
This will confirm the agreement we have reached with respect to the $13,904,336 of outstanding debt due and owing from Protalex, Inc. (“Protalex”) to Niobe Ventures, LLC (“Niobe”) as evidenced by promissory notes issued by Protalex to Niobe (the “Notes”).
